Orchid Pharma Limited (ORCHPHARMA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Orchid Pharma Limited (ORCHPHARMA) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs115.10 Million ≈ $1.24 Million USD) by net assets (Rs12.74 Billion ≈ $137.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Orchid Pharma Limited to measure how many days the company can operate on defensive assets alone.
Orchid Pharma Limited - Cash Flow Conversion Efficiency Trend (2004–2026)
This chart illustrates how Orchid Pharma Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Orchid Pharma Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Orchid Pharma Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BlackRock MIT II
NYSE:BLE
|
-0.063x |
|
Dingli Communications Corp Ltd
SHE:300050
|
0.082x |
|
Bright Oceans Inter Telecom Corp
SHG:600289
|
-0.244x |
|
Guangdong Hybribio Biotech Co Ltd
SHE:300639
|
0.018x |
|
Gulf Oil Lubricants India Limited
NSE:GULFOILLUB
|
0.014x |
|
Shenzhen Longtech Smart Control Co. Ltd.
SHE:300916
|
N/A |
|
Ambassador Hotel Ltd
TW:2704
|
0.009x |
|
Beijing Jingyeda Technology Co Ltd
SHE:003005
|
-0.012x |
Annual Cash Flow Conversion Efficiency for Orchid Pharma Limited (2004–2026)
The table below shows the annual cash flow conversion efficiency of Orchid Pharma Limited from 2004 to 2026. For the full company profile with market capitalisation and key ratios, see ORCHPHARMA stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs12.88 Billion ≈ $139.27 Million |
Rs1.10 Billion ≈ $11.88 Million |
0.085x | +462.76% |
| 2025-03-31 | Rs12.67 Billion ≈ $137.05 Million |
Rs192.15 Million ≈ $2.08 Million |
0.015x | -85.93% |
| 2024-03-31 | Rs11.69 Billion ≈ $126.47 Million |
Rs1.26 Billion ≈ $13.63 Million |
0.108x | +304.58% |
| 2023-03-31 | Rs6.89 Billion ≈ $74.47 Million |
Rs183.38 Million ≈ $1.98 Million |
0.027x | -81.36% |
| 2022-03-31 | Rs6.47 Billion ≈ $70.01 Million |
Rs924.75 Million ≈ $10.00 Million |
0.143x | +295.42% |
| 2021-03-31 | Rs6.53 Billion ≈ $70.61 Million |
Rs235.86 Million ≈ $2.55 Million |
0.036x | -65.76% |
| 2020-03-31 | Rs7.66 Billion ≈ $82.84 Million |
Rs808.03 Million ≈ $8.74 Million |
0.105x | +717.65% |
| 2019-03-31 | Rs-7.04 Billion ≈ $-76.14 Million |
Rs120.24 Million ≈ $1.30 Million |
-0.017x | -47.30% |
| 2018-03-31 | Rs-7.92 Billion ≈ $-85.63 Million |
Rs91.81 Million ≈ $992.84K |
-0.012x | +98.65% |
| 2017-03-31 | Rs-4.67 Billion ≈ $-50.48 Million |
Rs4.01 Billion ≈ $43.36 Million |
-0.859x | -119.85% |
| 2016-03-31 | Rs490.45 Million ≈ $5.30 Million |
Rs2.12 Billion ≈ $22.95 Million |
4.327x | +679.20% |
| 2015-03-31 | Rs3.29 Billion ≈ $35.62 Million |
Rs-2.46 Billion ≈ $-26.61 Million |
-0.747x | -353.59% |
| 2013-03-31 | Rs3.81 Billion ≈ $41.16 Million |
Rs1.12 Billion ≈ $12.12 Million |
0.295x | -52.70% |
| 2012-03-31 | Rs11.83 Billion ≈ $127.98 Million |
Rs7.37 Billion ≈ $79.71 Million |
0.623x | +100.87% |
| 2011-03-31 | Rs10.71 Billion ≈ $115.84 Million |
Rs3.32 Billion ≈ $35.92 Million |
0.310x | +947.20% |
| 2010-03-31 | Rs9.38 Billion ≈ $101.40 Million |
Rs-343.17 Million ≈ $-3.71 Million |
-0.037x | -150.53% |
| 2009-03-31 | Rs6.34 Billion ≈ $68.54 Million |
Rs459.01 Million ≈ $4.96 Million |
0.072x | -77.10% |
| 2008-03-31 | Rs6.65 Billion ≈ $71.92 Million |
Rs2.10 Billion ≈ $22.74 Million |
0.316x | +63.88% |
| 2007-03-31 | Rs4.85 Billion ≈ $52.46 Million |
Rs936.11 Million ≈ $10.12 Million |
0.193x | +1627.98% |
| 2006-03-31 | Rs7.76 Billion ≈ $83.88 Million |
Rs-97.95 Million ≈ $-1.06 Million |
-0.013x | -106.68% |
| 2005-03-31 | Rs4.61 Billion ≈ $49.83 Million |
Rs870.92 Million ≈ $9.42 Million |
0.189x | +667.99% |
| 2004-03-31 | Rs4.10 Billion ≈ $44.38 Million |
Rs-136.54 Million ≈ $-1.48 Million |
-0.033x | -- |
About Orchid Pharma Limited
Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins; human and veterinary products; and antibiotics, including betalactam, m… Read more